David G. Bruce
University of Western Australia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David G. Bruce.
Journal of the American Geriatrics Society | 2002
David G. Bruce; A. Devine; Richard L. Prince
OBJECTIVES: To examine whether fear of falling is a probable cause of reduced recreational physical activity levels in healthy older women.
JAMA Internal Medicine | 2008
Richard L. Prince; Nicole Austin; Amanda Devine; Ian M. Dick; David G. Bruce; Kun Zhu
BACKGROUND Ergocalciferol (vitamin D(2)) supplementation plays a role in fall prevention, but the effect in patients living in the community in sunny climates remains uncertain. We evaluated the effect of ergocalciferol and calcium citrate supplementation compared with calcium alone on the risk of falls in older women at high risk of falling. METHODS A 1-year population-based, double-blind, randomized controlled trial of 302 community-dwelling ambulant older women aged 70 to 90 years living in Perth, Australia (latitude, 32 degrees S), with a serum 25-hydroxyvitamin D concentration of less than 24.0 ng/mL and a history of falling in the previous year. Participants were randomized to receive ergocalciferol, 1000 IU/d, or identical placebo (hereinafter, ergocalciferol and control groups, respectively). Both groups received calcium citrate, 1000 mg/d. Fall data were collected every 6 weeks. RESULTS Ergocalciferol therapy reduced the risk of having at least 1 fall over 1 year after adjustment for baseline height, which was significantly different between the 2 groups (ergocalciferol group, 53.0%; control group, 62.9%; odds ratio [OR], 0.61; 95% confidence interval [CI], 0.37-0.99). When those who fell were grouped by the season of first fall or the number of falls they had, ergocalciferol treatment reduced the risk of having the first fall in winter and spring (ergocalciferol group, 25.2%; control group, 35.8%; OR, 0.55; 95% CI, 0.32-0.96) but not in summer and autumn, and reduced the risk of having 1 fall (ergocalciferol group, 21.2%; control group, 33.8%; OR, 0.50; 95% CI, 0.28-0.88) but not multiple falls. CONCLUSION Patients with a history of falling and vitamin D insufficiency living in sunny climates benefit from ergocalciferol supplementation in addition to calcium, which is associated with a 19% reduction in the relative risk of falling, mostly in winter.
Journal of the American Geriatrics Society | 2007
Nicole Austin; Amanda Devine; Ian Dick; Richard L. Prince; David G. Bruce
OBJECTIVES: To determine longitudinal predictors of incident and persistent fear of falling (FOF) in older women.
Journal of Diabetes and Its Complications | 2003
David G. Bruce; Wendy A. Davis; C A Cull; Timothy M. E. Davis
BACKGROUND Diabetic patients obtain knowledge of the condition from a variety of sources. These include education programs and encounters with health-care staff such as during instruction on self-monitoring of blood glucose (SMBG). OBJECTIVE To assess whether diabetes knowledge is related to prior attendance at diabetes education programs, visits to dieticians or the current use of SMBG in a community-based cohort of subjects with type 2 diabetes. PATIENTS 1264 type 2 patients from the Fremantle Diabetes Study (FDS) cohort. METHODS Subjects answered 15 standard multiple-choice questions about diabetes and its management. Recall of past diabetes education, dietician consultations, and use of SMBG were recorded. Analysis of variance was used to determine whether these activities or other social and demographic factors predicted diabetes knowledge. RESULTS Attendance at education programs, visits to dieticians, and SMBG were independently associated with greater diabetes knowledge. Subjects who were older, whose schooling was limited, who were not fluent in English and/or who were from Southern European or indigenous Australian ethnic groups had significantly lower knowledge scores. Patients who were older, not fluent in English or from an indigenous Australian background were significantly less likely to have received diabetes education, dietetic advice or to be performing SMBG. CONCLUSIONS Diabetes education programs, diabetes-related visits to dieticians and SMBG are associated with, and may be important sources of, improved diabetes knowledge in patients with type 2 diabetes. Our data provide evidence that barriers to access or utilization of contemporary diabetes education confront older patients, minority groups and those with language difficulties. These groups are likely to benefit from specialized programs.
Diabetic Medicine | 2000
Timothy M. E. Davis; P. Zimmet; Wendy A. Davis; David G. Bruce; S. Fida; Ian R. Mackay
SUMMARY
Diabetologia | 2006
Wendy A. Davis; Paul Norman; David G. Bruce; T. M. E. Davis
Aims/hypothesisThe aims of this study were to assess the incidence, predictors, consequences, and inpatient cost of lower extremity amputation (LEA) in a community-based cohort of type 2 diabetic patients.MethodsBetween 1993 and 1996, 1,294 patients with type 2 diabetes were recruited to the longitudinal, observational Fremantle Diabetes Study. LEAs and mortality from cardiac causes were monitored until 30 June 2005. Inpatient costs (in A
Diabetologia | 2005
David G. Bruce; Wendy A. Davis; Sergio E. Starkstein; Timothy M. E. Davis
in year 2000), derived using a case-mix approach, were available for the period from 1 July 1993 to 30 June 2000.ResultsDuring follow-up 44 patients without LEA at baseline had a first-ever diabetes-related LEA, an incidence of 3.8 per 1,000 patient-years. Independent predictors of first-ever LEA included foot ulceration (hazard ratio [95% CI]: 5.56 [1.24–25.01]), an ankle brachial index ≤0.90 (2.21 [1.11–4.42]), HbA1c (increase of 1%: 1.30 [1.10–1.54]) and neuropathy (2.65 [1.30–5.44]). The risk of cardiac death was significantly increased in patients with LEA at baseline, although this was not an independent risk factor. The median (interquartile range) inpatient cost per LEA admission was A
The Journal of Clinical Endocrinology and Metabolism | 2010
Timothy M. E. Davis; Simon G. A. Brown; Ian Jacobs; Max Bulsara; David G. Bruce; Wendy A. Davis
12,485 (A
Diabetes Research and Clinical Practice | 2003
David G. Bruce; Genevieve P. Casey; Valerie Grange; Roger C. Clarnette; Osvaldo P. Almeida; Jonathan K. Foster; Franklyn J. Ives; Timothy M. E. Davis
6,037–A
Journal of the American Geriatrics Society | 2010
Kun Zhu; Nicole Austin; Amanda Devine; David G. Bruce; Richard L. Prince
24,415), with a median length of stay of 24 (10–43) days.Conclusions/interpretationFirst-ever LEAs in type 2 patients were associated with poor glycaemic control, foot ulceration and evidence of microvascular and macrovascular disease. Patients with LEA were at increased risk of cardiac death. LEAs contribute disproportionately to diabetes-related inpatient costs.